RU94045832A - Cardioprotective agent for cardiac ischemic disease treatment - thiotriazoline - Google Patents

Cardioprotective agent for cardiac ischemic disease treatment - thiotriazoline

Info

Publication number
RU94045832A
RU94045832A RU94045832/14A RU94045832A RU94045832A RU 94045832 A RU94045832 A RU 94045832A RU 94045832/14 A RU94045832/14 A RU 94045832/14A RU 94045832 A RU94045832 A RU 94045832A RU 94045832 A RU94045832 A RU 94045832A
Authority
RU
Russia
Prior art keywords
cardioprotective agent
thiotriazoline
treatment
disease treatment
ischemic disease
Prior art date
Application number
RU94045832/14A
Other languages
Russian (ru)
Inventor
И.А. Мазур
Ua]
В.А. Бобров
А.Д. Визир
С.И. Пасечник
Original Assignee
Мазур И.А. (UA)
И.А. Мазур
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мазур И.А. (UA), И.А. Мазур filed Critical Мазур И.А. (UA)
Priority to RU94045832/14A priority Critical patent/RU94045832A/en
Publication of RU94045832A publication Critical patent/RU94045832A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FIELD: pharmacy. SUBSTANCE: product: 3-methyl-1,2,4-triazolyl-5-thioacetate formolinium is proposed as hepatoprotective, wound-healing and antiviral agent and for cardiac ischemia treatment. EFFECT: enhanced effectiveness, absence of by-side effects, decreased cost as compared with the known analogs. 1 cl

Claims (1)

Кардиопротекторное средство "Тиотриазолин" характеризуется новым применением морфолиния 3-метил-1,2,4-триазолил-5-тиоацетата, обладающего гепатопротекторным, ранозаживляющим и противовирусным свойствами, для лечения ишемической болезни сердца. Использование тиотриазолина в качестве кардиопротекторного средства для лечения ишемической болезни сердца имеет значительные преимущества перед известными аналогами по эффективности лечения, затратам на лечение и отсутствию побочных факторов.The cardioprotective agent "Thiotriazolin" is characterized by a new use of morpholine 3-methyl-1,2,4-triazolyl-5-thioacetate, which has hepatoprotective, wound healing and antiviral properties, for the treatment of coronary heart disease. The use of thiotriazolin as a cardioprotective agent for the treatment of coronary heart disease has significant advantages over known analogues in terms of treatment effectiveness, treatment costs and the absence of side factors.
RU94045832/14A 1994-12-08 1994-12-08 Cardioprotective agent for cardiac ischemic disease treatment - thiotriazoline RU94045832A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94045832/14A RU94045832A (en) 1994-12-08 1994-12-08 Cardioprotective agent for cardiac ischemic disease treatment - thiotriazoline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94045832/14A RU94045832A (en) 1994-12-08 1994-12-08 Cardioprotective agent for cardiac ischemic disease treatment - thiotriazoline

Publications (1)

Publication Number Publication Date
RU94045832A true RU94045832A (en) 1996-10-20

Family

ID=48450269

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94045832/14A RU94045832A (en) 1994-12-08 1994-12-08 Cardioprotective agent for cardiac ischemic disease treatment - thiotriazoline

Country Status (1)

Country Link
RU (1) RU94045832A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107831249A (en) * 2017-12-19 2018-03-23 武汉励合化学新材料有限公司 A kind of preparation of sulphur song oxazoline alkylbenzyldimethylasaltsum saltsum and its HPLC mass analysis methods

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107831249A (en) * 2017-12-19 2018-03-23 武汉励合化学新材料有限公司 A kind of preparation of sulphur song oxazoline alkylbenzyldimethylasaltsum saltsum and its HPLC mass analysis methods
CN107831249B (en) * 2017-12-19 2021-06-08 武汉励合生物医药科技有限公司 Preparation of thiabendazole morpholine salt and HPLC (high performance liquid chromatography) quality analysis method thereof

Similar Documents

Publication Publication Date Title
ATE180255T1 (en) GUANIDINE DERIVATIVES WITH THERAPEUTIC ACTION
CA2130275A1 (en) Use of Substituted Adenine Derivatives for Treating Multiple Sclerosis
MX9203543A (en) MEDICINE.
IT1206341B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE MYOCARDIUM ISCHHEMIA.
RU95106821A (en) Cyclopeptides, method of their synthesis, pharmaceutical composition and method of its preparing
CA2143610A1 (en) Use of norastemizole for the treatment of allergic disorders
GB1370973A (en) Therapeutic compositions
RU94045271A (en) Use of 2-phenyl-3-aroylbenzothiophenes for terner's syndrome inhibition
EP0342587A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
RU94045832A (en) Cardioprotective agent for cardiac ischemic disease treatment - thiotriazoline
ES2065980T3 (en) USE OF 5-AMINOSALICYLIC ACID IN THE TREATMENT OF DERMATOLOGICAL ALTERATIONS.
EP0199117A3 (en) New therapeutical use of phosphocreatine
ATE90359T1 (en) PEPTIDES.
CA2091134A1 (en) Therapeutic agent for threatened abortion
KR910009270A (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compound
DE68905076D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds.
ES455721A1 (en) Urapidil/furosemide compounds, compositions and use
AR008155A1 (en) USE OF A COMPOUND OF FORMULA I TO PREPARE A USEFUL MEDICINE TO TREAT AND PREVENT POST MENOPAUSIC CARDIOVASCULAR DISEASE IN WOMEN.
JPS6438030A (en) Preventing and treating agent for aids
RU97112901A (en) THROMBOLYTIC PRODUCTS
KR900016130A (en) 2-pyridylmethylthio derivatives and ulcer treatments
JO1673B1 (en) Novel polystyrenesulfonate
MX9605674A (en) Substituted benzenedicarboxylic acids diguanidides, process for their preparation, their use as medicament or diagnosis agent, as well as medicament containing them.
RU95121825A (en) PHARMACEUTICAL COMPOSITION THIMOCONANE AND 3'-AZIDOTHYMIDINE
RU92007154A (en) METHOD OF TREATMENT OF PURULENT-INFLAMMATORY DISEASES OF THE BODY CELLS